Your browser doesn't support javascript.
loading
Leukemic marrow infiltration reveals a novel role for Egr3 as a potent inhibitor of normal hematopoietic stem cell proliferation.
Cheng, Hui; Hao, Sha; Liu, Yanfeng; Pang, Yakun; Ma, Shihui; Dong, Fang; Xu, Jing; Zheng, Guoguang; Li, Shaoguang; Yuan, Weiping; Cheng, Tao.
Afiliación
  • Cheng H; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Collaborative Innovation Center for Cancer Medicine, Tianjin, China; Center for Stem Cell Medicine, Chinese Academy of Medical Sciences, Tianjin, China;
  • Hao S; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Collaborative Innovation Center for Cancer Medicine, Tianjin, China;
  • Liu Y; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Collaborative Innovation Center for Cancer Medicine, Tianjin, China;
  • Pang Y; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Collaborative Innovation Center for Cancer Medicine, Tianjin, China;
  • Ma S; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Collaborative Innovation Center for Cancer Medicine, Tianjin, China;
  • Dong F; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Collaborative Innovation Center for Cancer Medicine, Tianjin, China;
  • Xu J; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Collaborative Innovation Center for Cancer Medicine, Tianjin, China;
  • Zheng G; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Collaborative Innovation Center for Cancer Medicine, Tianjin, China;
  • Li S; Division of Hematology/Oncology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA; and.
  • Yuan W; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Collaborative Innovation Center for Cancer Medicine, Tianjin, China; Center for Stem Cell Medicine, Chinese Academy of Medical Sciences, Tianjin, China; Department of Stem Cell and Regenerative Me
  • Cheng T; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Collaborative Innovation Center for Cancer Medicine, Tianjin, China; Center for Stem Cell Medicine, Chinese Academy of Medical Sciences, Tianjin, China; Department of Stem Cell and Regenerative Me
Blood ; 126(11): 1302-13, 2015 Sep 10.
Article en En | MEDLINE | ID: mdl-26186938
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Médula Ósea / Células Madre Hematopoyéticas / Leucemia Experimental / Infiltración Leucémica / Proteína 3 de la Respuesta de Crecimiento Precoz Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Blood Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Médula Ósea / Células Madre Hematopoyéticas / Leucemia Experimental / Infiltración Leucémica / Proteína 3 de la Respuesta de Crecimiento Precoz Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Blood Año: 2015 Tipo del documento: Article